BRIM Biotechnology, Inc. (TPE:6885)
23.00
+0.05 (0.22%)
At close: Apr 29, 2026
BRIM Biotechnology Revenue
In the year 2025, BRIM Biotechnology had annual revenue of 5.49M TWD with 1,548.65% growth. BRIM Biotechnology had revenue of 2.59M in the quarter ending December 31, 2025, with 868.16% growth.
Revenue
5.49M
Revenue Growth
+1,548.65%
P/S Ratio
556.88
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.06B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HeXun Biosciences | 293.23M |
| SYN-TECH Chem. & Pharm. | 1.30B |
| Apex Biotechnology | 1.94B |
| Shine-On BioMedical | 30.00M |
| Syngen Biotech | 2.14B |
| Intech Biopharm | 107.53M |
| Genovate Biotechnology | 492.41M |
| 3D Global Biotech | 206.74M |